#News for #investors and #media: At #ERSCongress2024 we’ll be sharing our latest research across 56 abstracts including a late breaking alert session. We are redefining the future of respiratory medicine by building on decades of expertise to deliver ambitious, next generation treatment goals for hundreds of millions of people living with a variety of respiratory diseases like #asthma and #COPD. Learn more here: https://gsk.to/4e7vo99
Interesting event
I'm work in GSk products Sales man in GSk Calpol septran betnovate and other products sale
I wish one time work in your company
👏👏👏
Worth attending
I am impressed
Impressive
V
Senior researcher at Globaldata | Immediate joiner
2moThe GSK survey reveals a significant knowledge gap about respiratory syncytial virus (RSV) among adults over 50, with 60% unaware of the virus despite its serious risks for this demographic, particularly those with chronic conditions. RSV poses a substantial burden, causing over 470,000 hospitalizations annually in high-income countries, with severe outcomes in vulnerable groups. This underscores the urgent need for targeted educational initiatives to raise awareness and promote preventive measures. Global RSV Awareness Week is a commendable step, but sustained efforts are crucial to mitigate the impact of RSV and improve public health outcomes for at-risk populations.